> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# CDER Planning 103 New, Revised Draft Guidances in 2017
- URL: https://www.fdaweb.com/cder-planning-103-new-revised-draft-guidances-in-2017/
- Published: 2017-04-19T12:00:00.000Z
- Updated: 2026-09-14T22:18:31.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5138487

CDER has released a [list](https://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM417290.pdf?ref=fdaweb.com) of 103 new and revised draft guidances in 16 categories it plans to issue this calendar year. The categories and number of guidances included are: Advertising (1), Biopharmaceutics (3), Biosimilarity (2), Clinical/Antimicrobial (1), Clinical/Medical (12), Clinical Pharmacology (8), Clinical/Statistical (3), Drug Safety (3), Electronic Submissions (4), Generics (13), Labeling (6), Pharmaceutical Quality/CMC (11), Pharmaceutical Quality/Manufacturing Standards (CGMP) (4), Pharmacology/Toxicology (1), Procedural (29), and User Fees (2).